Table 1 The clinical risk factors for PE the women in this study had when enrolled in the prospective PREDO cohort
Inclusion criteria (clinical risk factors for PE) at enrolment in the PREDO cohort (at 12–14 weeks of gestation) | At-risk women who developed PE (PE group, n = 7) | At-risk women who did not develop PE (RC group, n = 6) |
|---|---|---|
PE during a previous pregnancy | 2 | 3 |
Small for gestational age newborn in a previous pregnancy | 2 | 2 |
Chronic hypertension | 0 | 1 |
Gestational diabetes in a previous pregnancy | 0 | 0 |
BMI over 30 | 2 | 2 |
Age under 20 | 0 | 0 |
Age over 40 | 1 | 0 |
Other: systemic lupus erythematosus, Sjögren’s syndrome, type 1 diabetes mellitus, fetal demise in a previous pregnancy | 0 | 0 |